Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Catrin Bauréus Koch is active.

Publication


Featured researches published by Catrin Bauréus Koch.


Radiation Research | 2010

Radiation immunomodulatory gene tumor therapy of rats with intracerebral glioma tumors.

Bertil Persson; Catrin Bauréus Koch; Gustav Grafström; Crister Ceberg; Per Munck af Rosenschöld; Henrietta Nittby; Bengt Widegren; Leif G. Salford

Abstract Single-fraction radiation therapy with 5 or 15 Gy 60Co γ radiation was combined with intraperitoneal injections of syngeneic interferon gamma (IFN-γ)-transfected cells in rats with intracerebral N29 or N32 glioma tumors at days 7, 21 and 35 after inoculation. For intracerebral N29 tumors, single-fraction radiation therapy with 5 or 15 Gy had no significant effect on the survival time. Immunization with IFN-γ-transfected N29 cells significantly increased the survival time by 61%. Single-fraction radiation therapy with 5 Gy combined with immunization increased the survival time significantly by 87% and complete remissions by 75% while with 15 Gy the survival time increased 45% with 38% complete remissions. For intracerebral N32 tumors, single-fraction radiation therapy with 15 Gy increased the survival time significantly by 20%. Immunization by itself had no significant effect with IFN-γ-transfected N32 cells, but combined with 15 Gy single-fraction radiation therapy it increased survival time significantly by 40%, although there were no complete remissions. Based on these findings, we suggest a new therapeutic regimen for malignant glioma using single-fraction radiation therapy with a target absorbed dose of the order of 5–10 Gy combined with clinically verified immunotherapy.


International Scholarly Research Notices | 2011

“Abscopal” Effect of Radiation Therapy Combined with Immune-Therapy Using IFN-γ Gene Transfected Syngeneic Tumor Cells, in Rats with Bilateral Implanted N29 Tumors

Bertil Persson; Catrin Bauréus Koch; Gustav Grafström; Crister Ceberg; Per Munck af Rosenschöld; Henrietta Nittby; Bengt Widegren; Leif G. Salford

The tumor growth rate response was studied on N29 rat glioma tumor cells subcutaneously implanted on both hind legs of Fischer-344 rats. At around 30 days after inoculation, RT was given with 60Co gamma radiation with 4 daily fractions of 5 Gy only to the right-lateral tumors. At days 26, 42, and 54 after inoculation, immunization was performed with irradiated syngeneic IFNγ-gene transfected cells. Tumor growth rate (TGR % per day) of the right-lateral irradiated tumor was significantly decreased (𝑃<0.01) after RT alone and with the combination of RT and immunization. But immunization alone gave no significant decrease of the TGR but significantly increased time of survival. The TGR of the unirradiated left-lateral tumors was significantly decreased (𝑃<0.02) only in the group of rats treated with RT alone. It is apparent that tumor cells killed by the radiation mediate suppression of tumor cells outside the target area. This effect is called the abscopal effect.


Technology in Cancer Research & Treatment | 2003

A Model for Evaluating Therapeutic Response of Combined Cancer Treatment Modalities: Applied to Treatment of Subcutaneously Implanted Brain Tumors (N32 and N29) in Fischer Rats with Pulsed Electric Fields (PEF) and 60 Co-gamma Radiation (RT)

Bertil Persson; Catrin Bauréus Koch; Gustav Grafström; Per Engström; Leif G. Salford

The aim of the present study is to develop a mathematical model for evaluating therapeutic response of combined treatment modalities. The study was performed in rats of the Fischer-344 strain with rat glioma N32 or N29 tumors implanted subcutaneously on the thigh of the hind leg. Pulsed electric fields, PEF, with 16 exponentially decaying pulses with a maximum electric field strength of 140 V/mm and t1/e= 1 ms were first applied to the tumors. Then within 5 min radiation therapy with60 Co-gamma radiation, RT, was given in daily fractions of 5 Gy. The animals were arranged into one group of controls and 3 groups of different kind of treatments: PEF only, RT only or combination of PEF + RT. At about 4 weeks after inoculation, the tumors were given the treatment sessions during one week. In 2 experimental series with totally 52 rats with N32 tumors, of which 16 were controls, were given 4 sessions of PEF treatments and RT (totally 20 Gy). In a special experimental series with totally 56 rats with N32 tumors, of which 10 were controls, the different groups were given 1, 2, 3 or 4 treatment sessions respectively. Another strain of glioma tumor, N29 with 62 tumors of which 14 were controls was studied in 2 series given 4PEF + 4RT and 2PEF + 4RT respectively. Fitting the data obtained from consecutive measurements of tumor volume (TV) of each individual tumor to an exponential model TV = TV0 · exp[TGR · t] estimated the tumor growth rate (TGR % per day) after the first day of treatment (t = 0). The TGR of N32 tumors treated with the combination of 4PEF + 4RT are significantly decreased compared to the controls (p < 0.0001), compared to RT alone (p < 0.0001) and compared to PEF alone (p < 0.001). The combined treatment of N32 gives significant effect on the tumor growth rate after 2, 3 and 4 treatment session while RT alone seems to be most efficient after one treatment of 5 Gy and PEF alone is most efficient after 2 treatments at 2 consecutive days. The TGR of N29 tumors treated with the combination of 4PEF + 4RT are significantly decreased compared to the controls (p < 0.05) but the combination of 2PEF + 4RT was more effective (p < 0.005). The specific therapeutic effect STE is defined as the difference between the average tumor growth rates of controls and exposed tumors divided by the average tumor growth rate of the controls. With 4PEF treatments alone the average STE value was 0.32 for N32 tumors and 0 for N29; for 4RT alone the STE values were 0.29 and 0.42 respectively, and for combined treatments 4PEF + 4RT 0.67 and 0.17 respectively. For the N29 tumors treated with 2PEF + 4RT the STE value was 0.53. The therapeutic enhancement ratio, TER, value increase with the number of treatment sessions and the TER of the combined treatments is above 1 in two of the N32 series, which indicates a synergistic effect of 4PEF + 4RT. This work demonstrate the use of our model for analyzing the combination PEF + RT, but it can also be used for evaluation the therapeutic effects of combining RT with chemotherapy or immunogene-therapy.


biomedical engineering and informatics | 2008

Survival of Rats with N29 Brain Tumours after Irradiation with 5 or 15 Gy and Immunization with IFN-gamma Secreting Tumour Cells

Bertil Persson; Catrin Bauréus Koch; Gustav Grafström; Crister Ceberg; Per Munck af Rosenschöld; Bengt Widegren; Leif G. Salford

Intra cerebral tumours were inoculated into the brain of Fischer-344 syngeneic rats. After one week they were treated with either 5 or 15 Gy of 60Co-gamma radiation. The first immunization was given 1 hour before the radiation treatment and then two more times with 14-day intervals. Immunization was performed with 3 times 106 radiation sterilized IFN-gamma secreting tumour cells (N29) injected intraperitoneally. Neither radiation therapy with 5 or 15 Gy nor immunization with N29 cells alone had any significant effect on the length of survival of N29 tumour bearing rats. But radiation therapy with 5 Gy combined with immunization with IFN-gamma secreting syngeneic N29 cells resulted in 63 % complete remissions and significantly (p < 0.05) increased survival for the tumour bearing rats. Corresponding combination with 15 Gy RT resulted in 50% complete remissions. There is a possibility of a synergistic effect by optimal combination of radiation therapy and immunization.


Bioelectromagnetics | 2006

Exposure of rat brain to 915 MHz GSM microwaves induces changes in gene expression but not double stranded DNA breaks or effects on chromatin conformation

Igor Belyaev; Catrin Bauréus Koch; Olle Terenius; Katarina Roxström-Lindquist; Lars Malmgren; Wolfgang H. Sommer; Leif G. Salford; Bertil Persson


Neuro-oncology | 2005

Immunization with autologous glioma cells transfected with IFN-g gene significantly prolongs survival in GBM-patients older than 50 years

Leif G. Salford; Eva Ask; Peter Siesjö; Gunnar Skagerberg; Catrin Bauréus Koch; Catarina Blennow; Anna Darabi; Christina Elfgren; Elisabet Englund; Shorena Janelidze; Elna-Marie Larsson; Åsa Lilja; Bertil Persson; Anna Rydelius; Susanne Strömblad; Edward Visse; Bengt Widegren


Neuro-oncology | 2004

Abstracts from the Ninth Annual Meeting of the Society for Neuro-Oncology

Leif G. Salford; Peter Siesjö; Gunnar Skagerberg; Edward Visse; Anna Darabi; Åsa Lilja; Catarina Blennow; Susanne Strömblad; Eva Ask; Anna Rydelius; Bertil Persson; Catrin Bauréus Koch; Elisabet Englund; Elna-Marie Larsson; Nils Mandahl; Bengt Widegren


Acta Scientiarum Lundensia; 2014(002), pp 1-30 (2014) | 2014

Immunization with syngeneic interferon-gamma (IFN-g) secreting tumour cells enhance the Therapeutic effect and Abscopal effect from combined treatment of subcutaneously implanted contra-lateral N29 tumours on Fischer rats with Pulsed electric fields (PEF) and 60Co-gamma radiation.

Bertil Persson; Catrin Bauréus Koch; Gustav Grafström; Crister Ceberg; Leif G. Salford; Bengt Widegren


Acta Scientiarum Lundensia; 2012(007), pp 1-21 (2012) | 2012

Treatment of tumour cell with 5-aza-2-deoxycytidine (DAC) for immune tumour therapy of Glioma in Fischer-344 rats

Bertil Persson; Per Engström; Gustav Grafström; Catrin Bauréus Koch; Bengt Widegren; Leif G. Salford


Neuro-oncology | 2005

Culturing of human tumor cells for use in immune gene tumor therapy

Bengt Widegren; Catrin Bauréus Koch; Anna Rydelius; Gun-Britt Nyberg; Sofia Järnum; Anna Darabi; Peter Siesjö; Edward Visse; Susanne Strömblad; Catarina Blennow; Gunnar Skagerberg; Xiaolong Fan; Nils Mandahl; Hans Olov Sjögren; Bertil Persson; Leif G. Salford

Collaboration


Dive into the Catrin Bauréus Koch's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge